RAPTA-C

CAS No. 372948-28-2

RAPTA-C( —— )

Catalog No. M34689 CAS No. 372948-28-2

RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.

Purity : >98% (HPLC)

COA Datasheet HNMR HPLC MSDS Handing Instructions
Size Price / USD Stock Quantity
5MG 160 In Stock
10MG 236 In Stock
25MG 404 In Stock
50MG 574 In Stock
100MG Get Quote In Stock
200MG Get Quote In Stock
500MG Get Quote In Stock
1G Get Quote In Stock

Biological Information

  • Product Name
    RAPTA-C
  • Note
    Research use only, not for human use.
  • Brief Description
    RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
  • Description
    RAPTA-C induces EAC cell cycle arrest and apoptosis via the mitochondrial and p53-JNK pathways, and can be used in the study of breast and ovarian cancer.
  • In Vitro
    ——
  • In Vivo
    ——
  • Synonyms
    ——
  • Pathway
    Apoptosis
  • Target
    Apoptosis
  • Recptor
    Apoptosis
  • Research Area
    ——
  • Indication
    ——

Chemical Information

  • CAS Number
    372948-28-2
  • Formula Weight
    463.35
  • Molecular Formula
    C16H26Cl2N3PRu
  • Purity
    >98% (HPLC)
  • Solubility
    ——
  • SMILES
    [Cl-][Ru+2]12345([Cl-])([CH]=6[CH]5=C4(C(C)C)[CH]3=[CH]2C61C)[P]78CN9CN(CN(C9)C7)C8
  • Chemical Name
    ——

Shipping & Storage Information

  • Storage
    (-20℃)
  • Shipping
    With Ice Pack
  • Stability
    ≥ 2 years

Reference

molnova catalog
related products
  • Sodium Oxamate

    Sodium Oxamate is an LDH inhibitor.?Sodium oxamate (SO) induces G2/M cell cycle arrest via downregulation of the CDK1/cyclin B1 pathway and promotes apoptosis through enhancement of mitochondrial ROS generation.

  • WM-3835

    WM-3835 is a novel and high-specific small molecule?inhibitor of Lysine Acetyltransferase 7 (KAT7, MYST2, HBO1)?, able to potently suppressed OS cell proliferation and migration, and leads to?apoptosis?activation.

  • Benzyl selenocyanate

    Benzyl selenocyanate is a chemopreventive agent that effectively inhibits chemically induced tumors at both initiation and postinitiation stages in animal models.